Literature DB >> 22449721

Patterns of [PSI (+) ] aggregation allow insights into cellular organization of yeast prion aggregates.

Jens Tyedmers1.   

Abstract

The yeast prion phenomenon is very widespread and mounting evidence suggests that it has an impact on cellular regulatory mechanisms related to phenotypic responses to changing environments. Studying the aggregation patterns of prion amyloids during different stages of the prion life cycle is a first key step to understand major principles of how and where cells generate, organize and turn-over prion aggregates. The induction of the [PSI (+) ] state involves the actin cytoskeleton and quality control compartments such as the Insoluble Protein Deposit (IPOD). An initially unstable transitional induction state can be visualized by overexpression of the prion determinant and displays characteristic large ring- and ribbon-shaped aggregates consisting of poorly fragmented bundles of very long prion fibrils. In the mature prion state, the aggregation pattern is characterized by highly fragmented, shorter prion fibrils that form aggregates, which can be visualized through tagging with fluorescent proteins. The number of aggregates formed varies, ranging from a single large aggregate at the IPOD to multiple smaller ones, depending on several parameters discussed. Aggregate units below the resolution of light microscopy that are detectable by fluorescence correlation spectroscopy are in equilibrium with larger aggregates in this stage and can mediate faithful inheritance of the prion state. Loss of the prion state is often characterized by reduced fragmentation of prion fibrils and fewer, larger aggregates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22449721      PMCID: PMC3399536          DOI: 10.4161/pri.18986

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  134 in total

1.  Destabilizing interactions among [PSI(+)] and [PIN(+)] yeast prion variants.

Authors:  Michael E Bradley; Susan W Liebman
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

2.  Distinct subregions of Swi1 manifest striking differences in prion transmission and SWI/SNF function.

Authors:  Zhiqiang Du; Emily T Crow; Hyun Seok Kang; Liming Li
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

3.  Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast.

Authors:  Simon Alberti; Randal Halfmann; Susan Lindquist
Journal:  Methods Enzymol       Date:  2010-03-01       Impact factor: 1.600

4.  Analysis of the [RNQ+] prion reveals stability of amyloid fibers as the key determinant of yeast prion variant propagation.

Authors:  Tejas Kalastavadi; Heather L True
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

5.  Prion induction involves an ancient system for the sequestration of aggregated proteins and heritable changes in prion fragmentation.

Authors:  Jens Tyedmers; Sebastian Treusch; Jijun Dong; J Michael McCaffery; Brooke Bevis; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

6.  Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1.

Authors:  Tatyana Rogoza; Alexander Goginashvili; Sofia Rodionova; Maxim Ivanov; Olga Viktorovskaya; Alexander Rubel; Kirill Volkov; Ludmila Mironova
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

7.  Pleiotropic effects of Ubp6 loss on drug sensitivities and yeast prion are due to depletion of the free ubiquitin pool.

Authors:  Tatiana A Chernova; Kim D Allen; Lisa M Wesoloski; John R Shanks; Yury O Chernoff; Keith D Wilkinson
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

8.  In vivo evidence for the fibrillar structures of Sup35 prions in yeast cells.

Authors:  Shigeko Kawai-Noma; Chan-Gi Pack; Tomoko Kojidani; Haruhiko Asakawa; Yasushi Hiraoka; Masataka Kinjo; Tokuko Haraguchi; Hideki Taguchi; Aiko Hirata
Journal:  J Cell Biol       Date:  2010-07-19       Impact factor: 10.539

9.  Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104.

Authors:  Dmitry S Kryndushkin; Ilya M Alexandrov; Michael D Ter-Avanesyan; Vitaly V Kushnirov
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

Review 10.  Propagation of yeast prions.

Authors:  Mick F Tuite; Brian S Cox
Journal:  Nat Rev Mol Cell Biol       Date:  2003-11       Impact factor: 94.444

View more
  6 in total

1.  Prokaryotic chaperones support yeast prions and thermotolerance and define disaggregation machinery interactions.

Authors:  Michael Reidy; Marika Miot; Daniel C Masison
Journal:  Genetics       Date:  2012-06-25       Impact factor: 4.562

Review 2.  Dynamic droplets: the role of cytoplasmic inclusions in stress, function, and disease.

Authors:  Triana Amen; Daniel Kaganovich
Journal:  Cell Mol Life Sci       Date:  2014-10-05       Impact factor: 9.261

3.  Heritable yeast prions have a highly organized three-dimensional architecture with interfiber structures.

Authors:  Helen R Saibil; Anja Seybert; Anja Habermann; Juliane Winkler; Mikhail Eltsov; Mario Perkovic; Daniel Castaño-Diez; Margot P Scheffer; Uta Haselmann; Petr Chlanda; Susan Lindquist; Jens Tyedmers; Achilleas S Frangakis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-27       Impact factor: 11.205

4.  Prion aggregate structure in yeast cells is determined by the Hsp104-Hsp110 disaggregase machinery.

Authors:  Jonathan O'Driscoll; Daniel Clare; Helen Saibil
Journal:  J Cell Biol       Date:  2015-10-05       Impact factor: 10.539

5.  The Insoluble Protein Deposit (IPOD) in Yeast.

Authors:  Stephanie Rothe; Abaya Prakash; Jens Tyedmers
Journal:  Front Mol Neurosci       Date:  2018-07-12       Impact factor: 5.639

6.  Design of a New [PSI +]-No-More Mutation in SUP35 With Strong Inhibitory Effect on the [PSI +] Prion Propagation.

Authors:  Lavrentii G Danilov; Andrew G Matveenko; Varvara E Ryzhkova; Mikhail V Belousov; Olga I Poleshchuk; Daria V Likholetova; Petr A Sokolov; Nina A Kasyanenko; Andrey V Kajava; Galina A Zhouravleva; Stanislav A Bondarev
Journal:  Front Mol Neurosci       Date:  2019-11-19       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.